Position in VKTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,663,273
New position
Shares Held
93,906
first reported quarter
Ownership
0.081%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#83
of 432 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026LBP AM SA holds $68,103,102 across 9 Biotechnology names. VKTX ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
388,498 | $36,149,738 | |
| 2 | INCY |
Incyte Corp
|
95,697 | $10,848,211 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,597 | $7,747,497 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,206 | $4,276,432 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
This page
|
93,906 | $3,663,273 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
17,947 | $2,057,982 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 8 | RPRX |
Royalty Pharma plc
|
22,589 | $1,266,565 |
All Filings in VKTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,663,273 | 93,906 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||